G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| P03070 | Large T antigen | ||
| P03372 | Estrogen receptor | ||
| P03897 | NADH-ubiquinone oxidoreductase chain 3 | ||
| P03966 | N-myc proto-oncogene protein | ||
| P04004 | Vitronectin | ||
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | ||
| P04040 | Catalase | ||
| P04049 | RAF proto-oncogene serine/threonine-protein kinase | ||
| P04062 | Lysosomal acid glucosylceramidase | ||
| P04066 | Tissue alpha-L-fucosidase |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Canis familiaris |
| E.coli O10 | Escherichia coli |
| E.coli O103 | Escherichia coli |
| E.coli O105 | Escherichia coli |
| E.coli O109 | Escherichia coli |
| E.coli O110 | Escherichia coli |
| E.coli O111 | Escherichia coli |
| E.coli O112ab | Escherichia coli |
| E.coli O113 | Escherichia coli |
| E.coli O115 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 37422472 | The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase | Yu Y | 2023 Jul 08 |
|
| 37446392 | Identification of Regulatory Molecular “Hot Spots” for LH/PLOD Collagen Glycosyltransferase Activity | Mattoteia D | 2023 Jul 07 |
|
| 37390815 | Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis | Su Y | 2023 Jul 06 |
|
| 37409796 | Efficient Production of N-Acetylneuraminic Acid in Escherichia coli Based on the UDP-N-Acetylglucosamine Biosynthetic Pathway | Zhao M | 2023 Jul 06 |
|
| 37357620 | Crystal structures of Na+,K+‐ATPase reveal the mechanism that converts the K+‐bound form to Na+‐bound form and opens and closes the cytoplasmic gate | Kanai R | 2023 Jul 06 |
|
| 37407593 | Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies | Metcalf MC | 2023 Jul 05 |
|
| 37400538 | Discovery of VH domains that allosterically inhibit ENPP1 | Solomon PE | 2023 Jul 03 |
|
| 37395731 | Author response: Sterol derivative binding to the orthosteric site causes conformational changes in an invertebrate Cys-loop receptor | De Gieter S | 2023 Jul 03 |
|
| 37224467 | O-linked N-acetylglucosamine modification is essential for physiological adipose expansion induced by high-fat feeding | Nakamoto A | 2023 Jul 01 |
|
| 37028871 | Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus | Pitirollo O | 2023 Jul 01 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025